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Laser-capture microdissection impairs activity-based protein
profiles for serine hydrolase in human lung adenocarcinoma
Abstract
Laser-capture microdissection (LCM) enables the selection of a specific and pure cell population from a
heterogenous tissue such as tumors. Activity-based protein profiling/profile (ABPP) is a chemical
technology using enzyme-specific active site-directed probes to read out the functional state of many
enzymes directly in any proteome. The aim of this work was to assess the compatibility of LCM with
downstream ABPP for serine hydrolase (SH) in human lung adenocarcinoma. Fresh frozen lung
adenocarcinoma tissue was stained with hematoxylin, toluidine blue, or methyl green (MG). Proteome
from stained tissue was labeled further with SH-directed probes, and ABPPs were determined on a
one-dimensional gel-based approach. This allowed us to assess the impact of staining procedures on
their ABPPs. The effect of the LCM process on ABPPs was assessed furthermore using MG-stained
lung adenocarcinoma tissue. The staining procedures led to strong changes in ABPPs. However, MG
staining seemed the most compatible with downstream ABPP. MG-stained, laser-captured,
microdissected tissue showed additional change in profiles as a result of the denaturing property of
extraction buffer but not to the microdissection process itself. LCM staining procedures but not
microdissection per se interfered with downstream ABPP and led to a strong change in ABPPs of SHs in
human lung adenocarcinoma.
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Laser-capture microdissection (LCM) enables the selection of a specific and pure cell population from a
heterogenous tissue such as tumors. Activity-based protein profiling/profile (ABPP) is a chemical technology
using enzyme-specific active site-directed probes to read out the functional state of many enzymes directly in
any proteome. The aim of this work was to assess the compatibility of LCM with downstream ABPP for serine
hydrolase (SH) in human lung adenocarcinoma. Fresh frozen lung adenocarcinoma tissue was stained with
hematoxylin, toluidine blue, or methyl green (MG). Proteome from stained tissue was labeled further with
SH-directed probes, and ABPPs were determined on a one-dimensional gel-based approach. This allowed us
to assess the impact of staining procedures on their ABPPs. The effect of the LCM process on ABPPs was
assessed furthermore using MG-stained lung adenocarcinoma tissue. The staining procedures led to strong
changes in ABPPs. However, MG staining seemed the most compatible with downstream ABPP. MG-stained,
laser-captured, microdissected tissue showed additional change in profiles as a result of the denaturing
property of extraction buffer but not to the microdissection process itself. LCM staining procedures but not
microdissection per se interfered with downstream ABPP and led to a strong change in ABPPs of SHs in
human lung adenocarcinoma.
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INTRODUCTION
Laser-capture microdissection (LCM) is an essential tool
in -omics sciences and was first described for proteomics a
decade ago.1 This tool enables the selection from a heteroge-
neous tissue of a specific cell population, for instance, tumor
tissue, to be analyzed further.2 As with other microscope-
based techniques, histological staining of the tissue section is
generally required and can consequently impede downstream
proteome analysis. Different staining methods suggested detri-
mental effects on subsequent protein separation techniques.3,4
Activity-based protein profiling/profile (ABPP) is a
chemical technology that allows a direct activity read-out of
members of distinct enzyme superfamilies in any given
proteome through the use of enzyme class-specific active
site-directed probes.5–7 ABPP probes selectively label active
enzymes but not their inactive forms (zymogen or inhibi-
tor-bound). As demonstrated by Jessani et al.8–10 for
KIAA1363 activity in estrogen receptor()/progesterone
receptor() breast cancers, this approach facilitates the
characterization of changes in enzyme activity that occur
without corresponding alterations in protein or transcript
expression. Consequently, ABPP is a powerful technique to
characterize disease-associated enzyme activities that may
evade detection by other molecular profiling methods.
Despite the use of LCM in proteomics, coupling LCM
with functional cancer proteomics such as ABPP has never
been described. This new approach could lead to tumor
cell-specific ABPPs determining new targets for enzyme
activitymodulating drugs. Coupling LCMandABPP tech-
nologies raises the problem of staining procedure duality:
On the one hand, a staining procedure may enable a good
image quality and an efficient microdissection, but on the
other hand, it may impair the recovered proteome with
corresponding ABPPs. The aim of this study was then to
assess the impact of LCM, including different staining
procedures [hematoxylin (H), toluidine blue (TB), methyl
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green (MG)], on downstream ABPPs for serine hydrolase
(SH) in human lung adenocarcinoma.
MATERIALS AND METHODS
The general experimental workflow is depicted in Figure 1.
Tissue and Section
A representative piece of lung adenocarcinoma tissue from
one resected patient was embedded in the cryopreservative
OCT and frozen in an isopentane bath immediately after
surgery. Storage was at 80°C until use. Thereafter, sec-
tions of 8m thickness weremanufactured with aHM560
Microm cryostat at 20°C, mounted on glass slides or
MembraneSlides (MMI, Glattbrugg, Switzerland), and
again, stored at 80°C until used.
Staining Procedures and LCM
Four different staining procedures were tested to visualize
frozen tumor tissue for LCM: 1. single fixation in 75% etha-
nol (OH) for 30 s. 2.H stainingwith sequential immersions in
70% OH (3 s), water (10 s), Mayer’s H (15 s), water (10 s),
and Scott’s tap water substitute (10 s); sections were then
dehydrated through gradedOH (70%, 95%, 95%, 10 s each;
100%,100%,30 s each) and cleared in xylene (230 s). 3.TB
staining was performed by immersion of slides in 0.5% w/v
TB in acetate buffer, pH 3.8 (10 s), followed by a 100%OH
rinse. We used a pH-3.8 buffer, as TB has been reported to
bind preferentially to nucleic acids rather than protein when
used at a pH less than 4.0.11 Sections were then dehydrated in
100% OH (210 s) and cleared in xylene (1 min). 4. MG-
stained sections were manufactured by fixation in 75% OH
(30 s) and staining in 0.5% w/v violet-free MG in 0.1 M
sodium acetate buffer for 10 s (pH 4.2). All of the chemicals
for staining were from Sigma (Buochs, Switzerland).
In all cases, sections were finally air-dried at room
temperature and stored in a dessicator on dry ice until
processed further.
A 10 magnification objective of a MMI UVCut
microdissector was used. Standard parameters were 75%
cutting speed, 50% laser focus, and 100% laser power.
Proteome Solubilization and Labeling
Undissected tissueswere scratched from the glass slides using a
#11 scalpel blade and suspended in Dulbecco’s PBS. Micro-
dissected tissues were extracted from the caps using radioim-
munoprecipitation assay (RIPA) EB (20mMHepes, pH 7.5,
150mM sodium chloride, 1%Nonidet P-40, 0.25% sodium
deoxycholate, 10% glycerol). All of the chemicals for staining
were from Sigma. Repeated incubation into liquid nitrogen
and syringing up and down (0.5ml BectonDickinsonU-100
insulin syringe) were used to solubilize proteome. Protein
concentration was determined using the Bio-RadDC protein
assay (Bio-Rad, Glattbrugg, Switzerland).
SHs from solubilized proteome were labeled in the
dark and during 1 h using FPs linked to a rhodamine
derivate reporter tag at a 2-M final concentration. The
labeled SH trypsin was considered as a positive control.
Denatured proteome before labeling was considered as
negative controls.
Signal Detection
Proteome (20 g) was loaded per gel lane after chemical
(loading dye) and heat denaturation (8 min at 90°C).
Proteins were separated by 10% one-dimensional (1D)-
SDS-PAGE. Fluorescence was detected by IGFS using a
9400 Amersham Typhoon scanner.
RESULTS
Compatibility of Staining Procedures with ABPP
Proteome from tumor tissue sections, which underwent
solubilization and labeling without any staining procedure
steps, was qualified as a reference or native proteome (no).
Other tissue sections were processed according to different
protocols, including OH, H, TB, and MG, followed by
proteome solubilization and FP labeling (Fig. 2).
FP-labeled trypsin was considered as the positive con-
trol (data not shown). Negative controls for each staining
procedure could exclude unspecific SH labeling as well as
any dyes’ autofluorescence (data not shown).
The reference or no profile showed at least 11 distinct
bands. In the case of OH, only five bands appeared. Protein
profiles of H- or TB-stained sections showed only one
unique band. Three bands were conserved for the ABPP
from MG-stained sections.
FIGURE 1
General experimental workflow from the fresh frozen biopsy to the
detection of ABPPs. E.B., Extraction buffer; FP, fluorophosphonate
probe; IGFS, in-gel fluorescence scanning.
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Compatibility of Microdissection with ABPP
Proteome from native and MG-stained tissue was pro-
cessed as described earlier, and profiles were equivalent as in
Figure 2 (Fig. 3, lanes 2 and 3).
To obtain 20 g protein, 15 MG-stained tissue sec-
tions were microdissected randomly during 354min, and a
total of 99.5 mm2 tissue or 7602 shapes was recovered.
RIPA EB was used to collect microdissected cells from the
caps (Fig. 3, lane 5). This processing gave the poorest
profile, with only one band left. To assess the influence of
dissection time and EB on that last major variation in
profile, these two conditions were mimicked separately
(Fig. 3, lanes 4 and 5, respectively). Varying microdissec-
tion time did not influence the ABPP, and the use of EB led
to the same profile as when the tissue was microdissected.
DISCUSSION
Until now, LCM has never been coupled to downstream
ABPP. In this study, the impact on ABPPs of different
LCM staining procedures as well as the microdissection
process was evaluated.
Compatibility of Staining Procedures with ABPP
On the one hand, a tissue staining procedure is encouraged,
as it increases cell discrimination and microdissection
efficiency.2 However, on the other hand, Craven et al.3,4
suggested a detrimental effect of staining components
on downstream conventional proteome analysis. In this
study, we assessed the three most commonly used LCM
staining procedures for proteomic analysis. As the eosin
(E) component of the H&E staining procedure was
suggested to affect protein focusing on a 2D gel-based
proteome analysis of cervix and kidney cortex, we used a
modified procedure containing H alone.2,4 The TB
staining procedure was the same as suggested by Moule-
dous et al.12 for microdissection of rat brain samples. In
our experiments, ABPPs of tissue treated with both
staining procedures did not conserve more than one
common band at 70 kDa. H and TB were then not good
candidates as LCM staining procedures when coupled to
ABPP. A MG staining procedure consisting of 30 s in
75% OH and a dip in 0.5% MG solution was reported
FIGURE 3
Compatibility of microdissection with ABPP. Influence of incubation
time (t), the use of EB, as well as LCM on ABPPs was evaluated on a
1D gel-based approach.
FIGURE 2
Compatibility of staining procedures with ABPP. Tumor tissue sec-
tions underwent OH fixation, H, TB, or MG procedures. Their re-
spective activity-based proteome profiles were detected by IGFS.
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for LCM of nasopharyngeal carcinoma and lung adeno-
carcinoma.13,14 This original procedure did not give a
homogeneously stained tissue all over the slide in our
experiments. The reason why is not clear, as we used the
same tissue type and section thickness as described by
Liu and collaborators.13 Mouledous and colleagues12
described that varying stain concentration and incuba-
tion time were required to optimize the ratio between
efficient LCM and detrimental effects on proteome. We
then modified this original procedure by increasing the
incubation time to 10 s. The profile of MG-stained
tissue was the most conserved of the three dyes, with
three conserved bands at approximately 70, 60, and 20
kDa.
ABPPs were strongly influenced by the three different
LCM staining procedures and lost the vast majority of
bands. This phenomenon was a result of the chemical
denaturing properties of the staining compounds, such as
OH. For example, when tissue was treated with a single
OH bath, about one-half of the signal disappeared. Indeed,
proteins lost their biological activity as a result of the loss of
their secondary and tertiary structure following the appli-
cation of OH (used in all three procedures for fixation
and/or dehydration). In this context, OH-denatured en-
zymes, including SHs and their substrates (FPs), could no
longer bind to their active site. In conventional proteomics,
where the biological activity of proteins does not play such
a key role, 30 s in 70% OH fixation was recommended to
microdissect brain regions, as only a minimal effect on
protein extraction and recovery was described.12
Compatibility of Microdissection with ABPP
As the MG staining procedure seemed to have the less
adverse effect on ABPPs of SH, it was used to further assess
the compatibility of microdissection with ABPP.
Profiles from microdissected tissue gave a poor profile
with only one band left. This led to the conclusion that the EB
was responsible for the adverse effect on protein activity and
not microdissection itself. These results confirmed our previ-
ous suggestions concerning the influence onprofiles of protein
denaturing compounds, as RIPA buffer also contains protein
denaturants. We faced one of the major limitations of the use
of LCMwith downstream ABPP, as EB contributes to main-
tain a sufficient proteome yield after LCM. PCR allowed
analysis down to the single-cell level in the case of genomic
studies, but such amplification is impossible with a protein-
based approach. Hence, proteome analysis of microdissected
cells without the use of EB would lead to an extremely long
dissection time. In our experience, approximately 6 h micro-
dissection allowed a recovery of 20 g proteome required for
downstream1D-SDS-PAGE. From the literature, recent pro-
tocols reported even days of microdissection per sample to
generate enoughmaterial (25g) for subsequent analysis by
2D-SDS-PAGE.15
Microdissection time was suggested to have an impact
on downstream proteome analysis, and less than 1 hmicro-
dissection was suggested.2 In our experiments, mimicking
variations ofmicrodissection time from 0 to 25min did not
influence the ABPP from MG-stained tissue.
CONCLUSION
LCM is a powerful tool for isolating highly pure cell
populations from a heterogeneous tissue section via direct
visualization of the cells. However, staining procedure steps
as well as the use of EB led to strong changes in ABPPs of
SHs as a result of their denaturing components. The mod-
ified MG staining procedure seemed to be the best candi-
date for LCM when coupled with downstream ABPP.
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